A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DEVICE

PaQ® Insulin Delivery Device

PaQ is a 3 day insulin delivery device which delivers U 100 rapid-acting insulin. Provides basal insulin at preset basal doses and bolus insulin (in 2 unit increments) with a push of a button.

DRUG

Insulin, Asp(B28)-

a fast-acting analog of human insulin

Trial Locations (1)

A-8036

Medical University of Graz, Graz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CeQur Corporation

INDUSTRY